This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Novo Nordisk A/s. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Lars Nordholm: Innovating in Reproductive Biology
Introduction
Lars Nordholm is a distinguished inventor based in Herlev, Denmark, with a robust record of innovation in the field of reproductive biology. With two patents to his name, he contributes significantly to advancements in the understanding and manipulation of meiosis, a crucial process in reproduction.
Latest Patents
Nordholm's latest patents focus on unique methodologies involving chemical compounds and sterol derivatives. His first patent, "Stimulation of Meiosis," addresses the application of specific chemical compounds that interfere with cholesterol biosynthesis. This invention is aimed at stimulating the meiosis of oocytes and spermatozoa both in vivo and ex vivo, highlighting its potential in both clinical and laboratory settings. The second patent, "Regulation of Meiosis Using Sterols," extends this work, introducing sterol derivatives for use as medicaments, providing new avenues for regulating meiosis.
Career Highlights
Lars Nordholm is affiliated with Novo Nordisk A/S, a leading global healthcare company known for its innovative approach to diabetes care and other serious chronic conditions. His work at Novo Nordisk showcases his dedication to pushing the boundaries of scientific research and innovation in reproductive health.
Collaborations
Throughout his career, Nordholm has collaborated with notable colleagues, including Anne Grete Byskov and Erling Guddal. These partnerships reflect a commitment to teamwork and the sharing of knowledge in the pursuit of groundbreaking discoveries.
Conclusion
Lars Nordholm stands out as a notable inventor in the field of reproductive biology, with impactful patents that could revolutionize our understanding and manipulation of meiosis. His affiliation with Novo Nordisk and his collaborations with esteemed coworkers underline his significant contribution to innovation in medical science. As research continues to evolve, Nordholm's work is likely to pave the way for new therapies and advancements in reproductive health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile